Monthly Archives: January 2013

NMEs of 2012

Before much more of  2013 slips by, here’s a review of the newly-FDA approved drugs of 2012. More specifically, we’re talking about NMEs or “new molecular entities”, as opposed to old drugs repackaged for new indications or reformulated for new routes … Continue reading

Posted in general | Tagged | 1 Comment